Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Glenmark Generics Inc., a division of Glenmark Generics, will deploy the Revitas Flex technology platform to support Glenmark's growth, manage revenue margins and automate the complete contract lifecycle on a single, standards-based platform.
Subscribe to our email newsletter
The implementation includes Revitas CARS, CARS BI, Medicaid Rebates and Government Pricing solutions.
Glenmark executive vice president Paul Dutra said the Flex platform is an end-to-end automated solution for revenue management integrated with contracting, compliance and reporting that will support its continued growth.
"The Flex platform meets our business requirements as a complete solution to automate critical pharmaceutical business processes," Dutra added.
The Flex platform assists generics manufacturers regarding automation capabilities to design business processes and eliminate errors along with visibility into sales contract data to ensure concurrence with government price reporting obligations.
Revitas president and COO Al Smith said Glenmark’s migration to the Flex platform validates the role of ERD in solving critical business issues for life sciences companies.
"Glenmark has been a valued Revitas customer for more than eight years and this latest milestone adds to the growing evidence that ERD is crucial for generics companies to optimize and automate their contracts, pricing, and compliance," Smith added.
Glenmark with the help of Flex platform is expected to have new tools for visibility, efficiency and automation which will optimize ERD through the use of life sciences-specific modules.